Last reviewed · How we verify
NCT05486156
Evaluation of a Multicomponent Nature-based Intervention for Well-being and Relationship With Nature
NA trial testing A Time with e-Nature in Well-being in 486 participants. Completed in 24 June 2023.
1 May 2023
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 486 |
| Start date | 8 October 2022 |
| Primary completion | 1 May 2023 |
| Estimated completion | 24 June 2023 |
| Sites | 6 locations across Brazil |
Drugs / interventions tested
- A Time with e-Nature
Conditions studied
- Well-being — all drugs for Well-being →
- Happiness — all drugs for Happiness →
Sponsor
Hospital Israelita Albert Einstein
Who can join
18 and older, any sex, with Well-being or Happiness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized clinical trial to evaluate the efficacy of a multi-component nature-based intervention on clinical outcomes for visitors from different natural areas in Brazil.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A time with e-Natureza (e-Nature): a model of nature-based health interventions as a complex adaptive system.
Leão ER, Hingst-Zaher E, Savieto RM, Patricio KP, et al · · 2023 · cited 2× · PMID 37674757 · DOI 10.3389/fpsyg.2023.1226197 -
Efficacy of a multicomponent nature-based intervention on well-being and environmental engagement: A randomized clinical trial.
Leão ER, Savieto RM, Borba GB, da Silva Victor E, et al · · 2025 · PMID 39874898 · DOI 10.1016/j.envint.2025.109286
Verify or expand the search:
- PubMed search for NCT05486156
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Well-being
Currently open trials in the same condition.
- NCT07237971 — Cocreating Action to Improve Rationality in the Health System · NA · recruiting
- NCT06651554 — Technology-assisted Methods to Advance Suicide Prevention Among Youth in Colombia · NA · recruiting
- NCT06943105 — Nonviolent Communication for Parents · NA · recruiting
- NCT06996418 — Intergenerational Mealtime at a Shared Site: A Small-scale Trial · NA · active not recruiting
- NCT06687304 — Light in Healthcare Environment (Ljus i sjukhusmiljö) · NA · recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05486156 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 19 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486156.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing